Stay updated on Augmenting TRD with Allopregnanolone Analog Clinical Trial
Sign up to get notified when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.

Latest updates to the Augmenting TRD with Allopregnanolone Analog Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide notice announces an NIH website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error instead of study results.SummaryDifference0.2%

- Check22 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study results.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study results page now displays a 403 Forbidden error, replacing the previous record content. This blocks viewing investigators, results, and related metadata on the page.SummaryDifference14%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This denotes a minor version update to the page's markup rather than content changes.SummaryDifference0.1%

Stay in the know with updates to Augmenting TRD with Allopregnanolone Analog Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.